Replies to post #126641 on Biotech Values

[jb_118]

I'd say these are "borderline" numbers. :)

Ran this past a path friend, here was his comment fwiw:

From my quick look, I think they are going to have to do a lot better than this to have something that is of any use. Most dermpaths think by morphology alone they only need help with a very small percentage of cases. It looks like these FISH probes pick up aneuploidy in a way that corresponds with morphologic atypia, and is positive in benign nevi with atypia to the tune of 10% if memory serves. This is just telling the pathologist what they already know, that the lesion is atypical. If I have a difficult case and you tell me the test misses ~20% of easily diagnosed malignancies (how does it do with tough ones? they threw those out), I have little faith in a negative result. Not that helpful.